VU MAI: Open Payments
NPI 1497086755 · MARRERO, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,265 in 78 payments from 17 companies in 2025. Trend: 2023 $1,103 · 2024 $1,190 · 2025 $1,265
Food & beverage: $1,265
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $279 |
| Astellas Pharma US Inc | 8 | $166 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $160 |
| AstraZeneca Pharmaceuticals LP | 6 | $124 |
| Vanda Pharmaceuticals Inc. | 5 | $110 |
| Novo Nordisk Inc | 5 | $84 |
| Corcept Therapeutics | 3 | $59 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $57 |
| Lilly USA, LLC | 3 | $56 |
| Axsome Therapeutics, Inc. | 2 | $40 |
Products named: Veozah, CAPLYTA, VRAYLAR, FANAPT, UBRELVY, Ozempic, BREZTRI, AIRSUPRA.
Industry payments across LA — which companies pay providers there.
